RET activation in adult and childhood papillary thyroid carcinoma using a reverse transcriptase-n-polymerase chain reaction approach on archival-nested material

British Journal of Cancer

Volumn 74, Issue 4, 1996, Pages 585-589

  Williams, G H ^a   Rooney, S ^a   Thomas, G A ^a   Cummins, G ^a   Williams, E D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

RET oncogene; Reverse transcriptase n polymerase chain reaction; Thyroid papillary carcinoma

Indexed keywords

PRIMER DNA; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CHILDHOOD CANCER; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; EXON; FEMALE; GENE ACTIVATION; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE RET; PRIORITY JOURNAL; PROTEIN DOMAIN; RACE DIFFERENCE; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; THYROID PAPILLARY CARCINOMA;

EID: 0029774070     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1996.405     Document Type: Article

References (32)

1. BARTRAM CR, DE, KA, HAGEMEIJER A, VAN AT, GEURTS KA, BOOTSMA D, GROSVELD G, FERGUSON SM, DAVIES T, STONE M, HEISTERKAMP N, STEPHENSON JR AND GROFFEN J. (1983). Translocation of c-abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia. Nature, 306, 277-280.
2. BAVERSTOCK K, EGLOFF B, PINCHERA A, RUCHTI C AND WILLIAMS ED. (1992). Thyroid cancer after Chernobyl. Nature, 359, 21-22.
3. BONGARZONE I, BUTTI MG, CORONELLI S, BORRELLO MG, SANTORO M, MONDELLINI P, PILOTTI S, FUCSO A, DELLA PORTA G AND PIEROTTI MA. (1994). Frequent activation of ret proto-oncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res., 54, 2979-2985.
4. BONGARZONE I, MONZINI N, BORRELLO MG, CARCANO C, FERRARESI G, ARIGHI E, MONDELLINI P, DELLA-PORTA G AND PIEROTTI MA. (1993). Molecular characterisation of a thyroid tumour specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit R1 alpha of cyclic AMP -dependent protein kinase A. Mol. Cell. Biol., 13, 358-366.
5. CARLSON KM, DOU S, CHI D, SCAVARDA N, TOSHIMA K, JACKSON CE, WILLS SA, GOODFELLOW PJ AND DONISKELLER H. (1994). Single missense mutation in the tyrosine kinase catalytic domain of the RET proto-oncogene is associated with multiple endocrine neoplasia type 2B. Proc. Natl Acad. Sci. USA, 91, 1579-1583.
6. CROZAT A, AMAN P, MANDHAL N AND RON D. (1993). Fusion of CHOP to a novel RNA binding protein in human myxoid liposarcoma. Nature, 363, 640-644.
7. DALLA-FAVERA R, BREGNI M, ERIKSON J, PATTERSON D, GALLO RC AND CROCE CM. (1982). Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc. Natl Acad. Sci. USA, 79, 7824-7827.
8. DONIS-KELLKR H, DOU S, CHI D, CARLSON KM, TOSHIMA K, LAIRMORE TC, HOWE JR, MOLEY JF, GOODFELLOW P AND WELLS SA. (1993). Mutations in the RET proto-oncogene are associated with MEN2A and FMTC. Hum. Mol. Genet., 2, 851-856.
9. ENG C, SMITH DP, MULLIGAN LM, NAGAI MA, HEALEY CS, PONDER MA, GARDNER E, SCHEUMANN GF, JACKSON CE AND TUNNACLIFFE A. (1994). Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet., 3, 237-241.
10. FABIEN N, PAULIN C, SANTORO M, BERGER N, GRIECO M, GALVAIN D, BARBIER Y, DUBOIS PM AND FUSCO A. (1992). Detection of RET oncogene activation in human papillary thyroid carcinomas by in situ hybridisation. Br. J. Cancer, 66, 1094-1098.
11. GALILI N, DAVIS RJ, FREDRICKS WJ, MUKHOPADHYAY S, RAUSCHER FJ, EMANUEL BS, ROVERA G AND BARR FG. (1993). Fusion of a head fork domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat. Genet., 3, 230-235.
12. GRECO A, PIEROTTI MA, BONGARZONE I, PAGLIARDINI I, LANZI C AND DELLA-PORTA G. (1992). TRK T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. Oncogene, 7, 237-242.
13. GRIECO M, SANTORO M, BERLINGIERI MT, MELILLO RM, DONGHI R, BONGARZONE I, PIEROTTI MA, DELLA-PORTA, FUSCO A AND VECCHIO G. (1990). PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas. Cell, 60, 557-563.
14. HARACH HR AND WILLIAMS ED. (1995). Childhood thyroid cancer in England and Wales. Br. J. Cancer, 72, 777-783.
15. HOFSTRA RM, LANDSVATER RM, CECCHERINI I, STULP RP, STELWAGEN T, LUO Y, PASINI B, HOPPENER JW, VAN-AMSTEL HK, ROMEO G, LIPS CS AND BUYS CH. (1994), A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 28 and sporadic medullary carcinoma. Nature, 367, 375-376.
16. ISHIZAKA Y, KOBAYASHI S, USHIJIMA T, HIROHASHI S, SUGIMURA T AND NAGO M. (1991). Detection of ret TPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene, 6, 1667-1672.
17. ITOH F, ISCHIZAKA Y, TAHIRA T, YAMAMOTO M, MIYA A, IMAI K, YACHI K, TAKAI S, SUGIMURA T AND NAGO M. (1992). Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients. Oncogene, 7, 1201-1206.
18. ITO T, SEYAMA T, IWAMOTO KS, MIZUNO T, TRONKO ND, KOMISSARENKO IV, CHERSTOVOY ED, SATOW Y, TAKEICHI N, DOHI K AND AKIYAMA M. (1994). Activated RET oncogene in thyroid cancers of children from areas contaminated by Chernobyl accident. Lancet, 344, 259.
19. JHIANG SM, CARUSO DR, GILMORE E, ISHIZAKA Y, TAHIRA T AND NAGAO M. (1991). Detection of the PTC/retPTC oncogene in human thyroid cancers. Oncogene, 7, 1331-1337.
20. KAZAKOV VK, DEMIDCHIK EP AND ASTAKHOVA LN. (1992). Nature, 359, 21.
21. MCWHIRTER WRM STILLER CA AND LENNOX EL. (1989). Carcinomas in childhood. A registry-based study of incidence and survival. Cancer, 63, 2242-2246.
22. MULLIGAN LM, KWOK JB, HEALEY CS, ELSDON MJ, ENG, C, GARDNER E, LOVE DR, MOLE SE, MOORE JK AND PAPI L. (1993). Germline mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature, 363, 458-460.
23. PACHNIS V, MANKOO B AND CONSTANTINI F. (1993). Expression of the c-ret proto-oncogene during mouse embryogenesis. Development, 119, 1005-1017.
24. PIEROTTI MA, SANTORO M, JENKINS RB, SOZZI G, BONGARZONE I, GRIECO M, MONZINI N, MIOZZO M, HERMANN MA, FUSCO A, HAY ID, DELLA PORTA G AND VECCHIO G. (1992). Characterisation of an inversion on the long arm of chromosome 10 juxtaposing D 1OS170 and RET and creating the oncogenic sequence RET/PTC. Proc. Natl Acad. Sci. USA, 89, 1616-1620.
25. SANTORO M, DATHAN N, BERLINGIERI MT, BONGAZONE I, PAULIN C, GRIECO M, PIEROTTI MA, VECCHIO G AND FUSCO A. (1994). Molecular characterisation of RET/PTC3, a novel rearranged version of the RET proto-oncogene, in a human thyroid papillary carcinoma. Oncogene, 9, 509-516.
26. SCHOENMAKERS EFP, WANSCHURA S, MOLS R, BULLERDIEK J, VAN DEN BERGH H AND VAN DE VEN, WJM. (1995). Recurrent rearrangements in the high mobility group protein gene, HMG1-C, in benign mesenchymal tumours. Nature Genet., 10, 436-444.
27. TAKAHASHI M AND COOPER GM. (1987). Mol. Cell. Biol., 7, 1378-1385.
28. TAKAHASHI M, BUMA Y, IWAMOTO T, INAGUMA Y, IKEDA H AND HIAI H. (1988). Oncogene, 3, 571-578.
29. WILLIAMS ED, PINCHERA A, KARAOGLOU A AND CHADWICK KH. (1993). Radiation Protection Research and Training Programme, Commission of the European Communities, EUR15248: Brussels.
30. WILLIAMS GH AND WILLIAMS ED. (1995). Identification of the tumour specific translocations in archival material. J. Pathol., 175, 279-281.
31. ZOU M, SHI Y AND FARID NR. (1994). Low rate of ret protooncogene activation (PTC/retTPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer, 73, 176-180.
32. ZUCMAN J, DELATTRE O, DESMAZE C, PLOUGASTEL B, JOUBERT I, MELOT T, PETER M, DE-JONG P, ROULEAU G AND AURIAS A. (1993). Cloning and characterisation of the Ewing's sarcoma and peripheral neuroepithelioma t(11:22) translocation breakpoints. Genes Chrom. Cancer, 4, 271-277.